0000000000477128

AUTHOR

C. Da Silva

showing 2 related works from this author

Measurement of CP asymmetry in Bs0 → Ds ∓K± decays

2014

Journal of high energy physics 2018(3), 59 (2018). doi:10.1007/JHEP03(2018)059

B physicCKM angle gamma01 natural sciencesB physicsLuminosityFlavor physicsHadron-Hadron scattering (experiments)TOOLLHCb - Abteilung HintonQCmedia_commonPhysicsParticle physicsCharge conjugation parity time reversal and other discrete symmetrie12.15.HhB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron ScatteringJustice and Strong InstitutionsCP violationB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron Scattering; Nuclear and High Energy PhysicsFísica nuclearLHCAstrophysics::Earth and Planetary AstrophysicsParticle physicsNuclear and High Energy PhysicsVIOLATIONSDG 16 - PeaceVIOLATION; GAMMA; TOOLAstrophysics::High Energy Astrophysical Phenomenamedia_common.quotation_subject14.40.NdLHCb - Abteilung HofmannAstrophysics::Cosmology and Extragalactic AstrophysicsHadrons530Determination of Cabibbo-Kobayashi & Maskawa (CKM) matrix elementAsymmetryNOHadronic decays of bottom mesonTheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITY0103 physical scienceslcsh:Nuclear and particle physics. Atomic energy. Radioactivityddc:530010306 general physicsLarge Hadron Collider (France and Switzerland)Astrophysics::Galaxy AstrophysicsHadron-Hadron Scattering010308 nuclear & particles physicsSDG 16 - Peace Justice and Strong InstitutionsGran Col·lisionador d'HadronsGAMMA/dk/atira/pure/sustainabledevelopmentgoals/peace_justice_and_strong_institutionsHEPLHCbFlavor physic13.25.HwB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron scattering (experiments)lcsh:QC770-798Bottom mesons (|B|>0)11.30.ErHigh Energy Physics::ExperimentB physics CKM angle gamma CP violation Flavor physics Hadron-Hadron ScatteringFísica de partículesExperiments
researchProduct

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

2021

Abstract Background Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results NNVs were more favourable in su…

MaleCOVID-19 Vaccinesafe surgery; vaccination modelling; COVID-19Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]MULTICENTERComorbidity030230 surgery0302 clinical medicinephase 3 clinical trial (topic)Case fatality rateProspective StudiesSARS-CoV-2 Vaccination Safe surgeryCOVID-19/epidemiologySARS-CoV-2 ; vaccination ; safe surgeryeducation.field_of_studycase fatality rateVaccinationVaccinationAdolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Postoperative Complications; Preoperative Period; Prospective Studies; SARS-CoV-2; Vaccination; Young Adulthealth care policyElective Surgical Procedures030220 oncology & carcinogenesisvaccination modellingPreoperative PeriodCOVID-19; SARS-CoV-2; cancer; vaccination; outcome; mortality; infection; modellingCohort studyprospective studyHumanmedicine.medical_specialtyArticle03 medical and health sciencesSARS-CoV-2 vaccinationSDG 3 - Good Health and Well-beingCOVID-19 Vaccines/pharmacologyHumansVaccination/methodsElective surgeryeducationAgedScience & TechnologyElective Surgical Procedureadult; aged; Article; cancer grading; cancer surgery; case fatality rate; computer assisted tomography; elective surgery; female; follow up; health care policy; human; incidence; infection rate; infection risk; major clinical study; male; middle aged; mortality; outcome assessment; phase 3 clinical trial (topic); preoperative care; prospective study; sensitivity analysis; seroprevalence; Severe acute respiratory syndrome coronavirus 2; vaccination; young adult; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Postoperative Complications; Preoperative Period; SARS-CoV-2; Vaccination; surgery.Cura preoperatòriamajor clinical studymortalityinfectionProspective StudieincidenceSurgeryHuman medicinePostoperative Complication610 Medizin und GesundheitAcademicSubjects/MED00910Settore MED/18 - CHIRURGIA GENERALESettore MED/29 - CHIRURGIA MAXILLOFACCIALEcomputer assisted tomographyESTUDOS PROSPECTIVOSsurgerysafe surgeryPostoperative Complicationssensitivity analysisSevere acute respiratory syndrome coronavirus 2preoperative careVacunacióProspective cohort studyseroprevalenceIncidence (epidemiology)covidElective Surgical Procedures/methodsMiddle Agedcancer gradingCOVID vaccinationoutcome/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSARS-CoV-2; vaccination; surgeryOriginal ArticleFemalecancer surgeryAcademicSubjects/MED00010Life Sciences & BiomedicineAdultCOVID-19 VaccinesAdolescentinternational prospective cohort studyPostoperative Complications/prevention & controlPopulationinfection rateSARS-CoV-2/immunologyNOmodellingYoung Adultmedicinefollow upcancerddc:610infection riskoutcome assessmentLS7_4business.industrySARS-CoV-2Number needed to vaccinatePreoperative careCOVID-193126 Surgery anesthesiology intensive care radiologySettore MED/18Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]elective surgeryEmergency medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyThe British Journal of Surgery
researchProduct